Solomon Gets Nearly $5M In Spirogen Sale Dispute
By William Gorta ( May 10, 2017, 7:04 PM EDT) -- A New York federal judge on Wednesday awarded investment banking advisory firm Peter J. Solomon Co. LP nearly $5 million in fees and interest from the $200 million sale of the British biotech formerly known as Spirogen Ltd. to an to an AstraZeneca PLC subsidiary....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.